Invention Grant
US08637315B2 Process, vectors and engineered cell lines for enhanced large-scale transfection
有权
过程,载体和工程细胞系,用于增强大规模转染
- Patent Title: Process, vectors and engineered cell lines for enhanced large-scale transfection
- Patent Title (中): 过程,载体和工程细胞系,用于增强大规模转染
-
Application No.: US12989898Application Date: 2009-03-09
-
Publication No.: US08637315B2Publication Date: 2014-01-28
- Inventor: Yves Durocher , Martin Loignon
- Applicant: Yves Durocher , Martin Loignon
- Applicant Address: CA Ottawa, Ontario
- Assignee: National Research Council of Canada
- Current Assignee: National Research Council of Canada
- Current Assignee Address: CA Ottawa, Ontario
- Agent Sonia Patenaude
- International Application: PCT/CA2009/000263 WO 20090309
- International Announcement: WO2009/137911 WO 20091119
- Main IPC: C12N15/87
- IPC: C12N15/87 ; C07K14/07

Abstract:
Processes vectors and engineered cell lines for large-scale transfection and protein production in mammalian cells, especially Chinese Hamster Ovary (CHO) cells are described in which transfection efficiencies are realized through the use of a single vector system, the use of functional oriP sequences in all plasmids, the use of codon-optimized Epstein-Barr virus nuclear antigen-1 (EBNA1) constructs the use of a fusion protein between a truncated Epstein-Barr virus nuclear antigenen-1c (EBNA1c) protein and a herpes simplex virus protein VP16, the use of a 40 kDa fully deacetylated poly(ethylenimine) as a transfection reagent, the use of co-expression of a fibroblast growth factor (FGF) and/or the use of protein kinase B to potentiate heterologous gene expression enhancement by valproic acid (VPA).
Public/Granted literature
- US20110039339A1 Process, Vectors and Engineered Cell Lines for Enhanced Large-Scale Transfection Public/Granted day:2011-02-17
Information query
IPC分类: